High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia.

High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia.

Antimonials are still being used for visceral leishmaniasis (VL) treatment among HIV co-infected patients in East-Africa due to the shortage of alternative safer drugs like liposomal amphotericin B. Besides tolerability, emergence of resistance to antimonials is a major concern.This study was aimed...

Full description

Bibliographic Details
Main Authors:	Ermias Diro, Lutgarde Lynen, Rezika Mohammed, Marleen Boelaert, Asrat Hailu, Johan van Griensven
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-05-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC4031116?pdf=render

Similar Items

Visceral Leishmaniasis and HIV coinfection in East Africa.
by: Ermias Diro, et al.
Published: (2014-06-01)

Visceral leishmaniasis as an AIDS defining condition: towards consistency across WHO guidelines.
by: Johan van Griensven, et al.
Published: (2014-07-01)

Multiple Relapses of Visceral Leishmaniasis in HIV Co-Infected Patients: A Case Series from Ethiopia
by: Rezika Mohammed, et al.
Published: (2020-01-01)

Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.
by: Ermias Diro, et al.
Published: (2015-01-01)

Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia.
by: Charles Abongomera, et al.
Published: (2017-01-01)

Efficacy and safety of a combined treatment of sodium stibogluconate at 20mg/kg/day with upper maximum daily dose limit of 850mg and Paromomycin 15mg/kg/day in HIV negative visceral leishmaniasis patients. A retrospective study, northwest Ethiopia.
by: Aschalew Tamiru, et al.
Published: (2021-08-01)

Anticipating visceral leishmaniasis epidemics due to the conflict in Northern Ethiopia.
by: Carl Boodman, et al.
Published: (2023-03-01)

Anticipating visceral leishmaniasis epidemics due to the conflict in Northern Ethiopia
by: Carl Boodman, et al.
Published: (2023-03-01)

Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya
by: Moore Elinore, et al.
Published: (2001-01-01)

Sodium stibogluconate-associated acute interstitial nephritis in a patient treated for visceral leishmaniasis
by: Sanjay Vikrant, et al.
Published: (2015-01-01)

Treatment of Cutaneous Leishmaniasis with Sodium Stibogluconate and Allopurinol in a Routine Setting in Ethiopia: Clinical and Patient-Reported Outcomes and Operational Challenges
by: Saskia van Henten, et al.
Published: (2023-08-01)

Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial.
by: Ahmed Musa, et al.
Published: (2012-01-01)

Bacterial sepsis in patients with visceral leishmaniasis in Northwest Ethiopia
by: M.E. Seid, et al.
Published: (2014-04-01)

Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia
by: Johan van Griensven, et al.
Published: (2018-03-01)

Abdominal ultrasound in the diagnostic work-up of visceral leishmaniasis and for detection of complications of spleen aspiration.
by: Rezika Mohammed, et al.
Published: (2021-02-01)

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.
by: Monique Wasunna, et al.
Published: (2016-09-01)

Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination
by: Hermali Silva, et al.
Published: (2021-01-01)

Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination.
by: Hermali Silva, et al.
Published: (2021-01-01)

Cutaneous Leishmaniasis Due to Leishmania aethiopica
by: Saskia van Henten, et al.
Published: (2018-12-01)

Effectiveness of intralesional sodium stibogluconate for the treatment of localized cutaneous leishmaniasis at Boru Meda general hospital, Amhara, Ethiopia: Pragmatic trial.
by: Feleke Tilahun Zewdu, et al.
Published: (2022-09-01)

A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan - A Retrospective Cohort Study.
by: Charles Abongomera, et al.
Published: (2016-01-01)

Epidemiology of visceral leishmaniasis in Shebelle Zone of Somali Region, eastern Ethiopia
by: Getachew Alebie, et al.
Published: (2019-05-01)

The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
by: Charles Abongomera, et al.
Published: (2018-05-01)

Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia.
by: Saskia van Henten, et al.
Published: (2021-05-01)

Control of visceral leishmaniasis in latin america-a systematic review.
by: Gustavo A S Romero, et al.
Published: (2010-01-01)

Cutaneous Necrosis after the Injection of Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis: A Rare Case Report
by: Bahareh Abtahi-naeini, et al.
Published: (2019-08-01)

Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell
by: M. Junaid Dar, et al.
Published: (2018-01-01)

The efficacy and safety of intralesional sodium stibogluconate for the treatment of cutaneous Leishmaniasis in children under the age of two years
by: Nawfal R Hussein, et al.
Published: (2020-04-01)

An epidemiological study of visceral leishmaniasis in North East Ethiopia using serological and leishmanin skin tests.
by: Desalegn Tadese, et al.
Published: (2019-01-01)

Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia.
by: Ermias Diro, et al.
Published: (2019-02-01)

Quantifying the contribution of hosts with different parasite concentrations to the transmission of visceral leishmaniasis in Ethiopia.
by: Ezer Miller, et al.
Published: (2014-10-01)

Randomized, double-blind study on intralesional metronidazole versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis
by: Vijani N. Somaratne, et al.
Published: (2019-01-01)

Leishmaniasis of the lip diagnosed by lymph node aspiration and treated with a combination of oral ketaconazole and intralesional sodium stibogluconate
by: Biju Vasudevan, et al.
Published: (2011-01-01)

Host transcriptomic signature as alternative test-of-cure in visceral leishmaniasis patients co-infected with HIV
by: Wim Adriaensen, et al.
Published: (2020-05-01)

Characteristics of bacterial sepsis among patients with visceral leishmaniasis
by: Mengistu Endris, et al.
Published: (2014-11-01)

Visceral leishmaniasis: new health tools are needed.
by: Asrat Hailu, et al.
Published: (2005-07-01)

Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial
by: Kinoti Dedan, et al.
Published: (2011-06-01)

Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients
by: Wim Adriaensen, et al.
Published: (2018-12-01)

Visceral leishmaniasis relapse in HIV patients--a role for myeloid-derived suppressor cells?
by: Rafael Van den Bergh, et al.
Published: (2014-09-01)

Epidemiology of visceral leishmaniasis in Algeria: an update.
by: Amel Adel, et al.
Published: (2014-01-01)